Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
At Dana-Farber, we offer many clinical trials for patients with all types of lymphoma. We invite you to view these informative videos, in which our physicians provide updates on many of these trials, as well as next steps for clinical research to improve
outcomes for blood cancer patients.
Dr. Jacobson on the research that led to the FDA approval of CAR T-cell therapy for mantle cell lymphoma in July 2020, Caron Jacobson, MD, MMSc (Source: Dana-Farber)
New Patient Appointments
Clinical Trials Questions?